People: Shanghai Kaibao Pharmaceutical Co Ltd (300039.SZ)
300039.SZ on Shenzhen Stock Exchange
14.40CNY
17 May 2013
14.40CNY
17 May 2013
Price Change (% chg)
¥-0.36 (-2.44%)
¥-0.36 (-2.44%)
Prev Close
¥15.34
¥15.34
Open
¥14.67
¥14.67
Day's High
¥14.68
¥14.68
Day's Low
¥14.01
¥14.01
Volume
10,416,233
10,416,233
Avg. Vol
5,893,032
5,893,032
52-wk High
¥16.25
¥16.25
52-wk Low
¥9.59
¥9.59
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Yishan Liu |
55 | Chairman of the Board | |
Liwang Ren |
42 | Chief Financial Officer | |
Guoming Wang |
49 | General Manager, Director | |
Jingwei Mu |
33 | 2011 | Secretary of the Board, Deputy General Manager |
Shaoyong Liu |
48 | 2011 | Deputy General Manager, Director |
Dongsheng Xue |
43 | 2011 | Deputy General Manager, Director |
Chongbang Wang |
49 | 2012 | Deputy General Manager |
Yingjun Zhu |
42 | Deputy General Manager | |
Mingwei Feng |
42 | 2011 | Director |
Laian Mu |
57 | 2008 | Director |
Enxiang Chao |
77 | Independent Director | |
Jianfang Feng |
47 | 2011 | Independent Director |
Jing Han |
35 | 2011 | Independent Director |
Biographies
| Name | Description |
|---|---|
Yishan Liu |
Mr. Liu Yishan is Chairman of the Board in Shanghai Kaibao Pharmaceutical CO.,LTD. Previously, he was Deputy Manager of a Henan-based medical group company and Deputy Head of Factory in a pharmaceutical factory. |
Liwang Ren |
Mr. Ren Liwang is Chief Financial Officer in Shanghai Kaibao Pharmaceutical CO.,LTD. He used to be Deputy Head-Finance and Head-Finance in the former entity of the Company. |
Guoming Wang |
Mr. Wang Guoming is General Manager and Director of Shanghai Kaibao Pharmaceutical CO.,LTD. Previously, he was Workshop Supervisor and Deputy General Manager in a China-based pharmaceutical factory, Workshop Supervisor and Deputy General Manager in a pharmaceutical company, as well as Deputy General Manager in the Company's former entity. |
Jingwei Mu |
Ms. Mu Jingwei has been Secretary of the Board and Deputy General Manager in Shanghai Kaibao Pharmaceutical CO.,LTD. since November 28, 2011. She previously served as Head of Enterprise Management Office in a Henan-based pharmaceutical company. |
Shaoyong Liu |
Mr. Liu Shaoyong has been Deputy General Manager and Director of Shanghai Kaibao Pharmaceutical CO.,LTD. since November 28, 2011. Previously, he was Workshop Supervisor and Section Head of Technology in a pharmaceutical factory, as well as Head-Quality Assurance, Head-Technology, Chief Engineer and Deputy General Manager in the former entity of the Company. |
Dongsheng Xue |
Mr. Xue Dongsheng has been Deputy General Manager and Director in Shanghai Kaibao Pharmaceutical CO.,LTD. since November 28, 2011. He was Assistant General Manager and Head-Production Technology Management of the Company. |
Chongbang Wang |
Mr. Wang Chongbang has been Deputy General Manager of Shanghai Kaibao Pharmaceutical CO.,LTD. since October 16, 2012. He used to be Executive Deputy Manager-Northern China Area of Sales in the Company, as well as Workshop Supervisor in another pharmaceutical company. |
Yingjun Zhu |
Mr. Zhu Yingjun is Deputy General Manager of Shanghai Kaibao Pharmaceutical CO.,LTD. Previously, he was Head of General Office in two Henan-based pharmaceutical companies, as well as Head-Supply Business and Assistant General Manager in the former entity of the Company. |
Mingwei Feng |
Mr. Feng Mingwei has been Director in Shanghai Kaibao Pharmaceutical CO.,LTD. since November 28, 2011. He is also Executive Manager-Southern China Area of the Company. He used to be Deputy Manager-Sales of Southern China Area in another pharmaceutical company. |
Laian Mu |
Mr. Mu Laian has been Director of Shanghai Kaibao Pharmaceutical CO.,LTD. since August 26, 2008. He is also serving as Director of three other Henan-based companies. Previously, he served as General Manager of a Henan-based pharmaceutical group company and Chairman of the Board in the Company's former entity. |
Enxiang Chao |
Mr. Chao Enxiang is Independent Director of Shanghai Kaibao Pharmaceutical CO.,LTD. He is also serving as Professor of Beijing University of Chinese Medicine and Tianjin University of Traditional Chinese Medicine, as well as Section Head of World Federation of Chinese Medicine Societies. |
Jianfang Feng |
|
Jing Han |
Ms. Han Jing has been Independent Director in Shanghai Kaibao Pharmaceutical CO.,LTD. since November 28, 2011. She is also Chief Financial Officer in two Shanghai-based apparel company. She used to be Chief Financial Officer in a sports protection industry group company. She is a Certified Public Accountant and Certified Internal Auditor. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Yishan Liu |
460,000 |
Liwang Ren |
180,000 |
Guoming Wang |
310,000 |
Jingwei Mu |
180,000 |
Shaoyong Liu |
210,000 |
Dongsheng Xue |
180,000 |
Chongbang Wang |
102,999 |
Yingjun Zhu |
180,000 |
Mingwei Feng |
180,000 |
Laian Mu |
-- |
Enxiang Chao |
60,000 |
Jianfang Feng |
60,000 |
Jing Han |
60,000 |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Yishan Liu |
0 | 0 |
Liwang Ren |
0 | 0 |
Guoming Wang |
0 | 0 |
Jingwei Mu |
0 | 0 |
Shaoyong Liu |
0 | 0 |
Dongsheng Xue |
0 | 0 |
Chongbang Wang |
0 | 0 |
Yingjun Zhu |
0 | 0 |
Mingwei Feng |
0 | 0 |
Laian Mu |
0 | 0 |
Enxiang Chao |
0 | 0 |
Jianfang Feng |
0 | 0 |
Jing Han |
0 | 0 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
